Menu

Editas Medicine, Inc. EDIT

Full chart Compare
Set alert

Price alert · EDIT

All alert types
2.57 USD +0.02 (+0.78%)

At closeNov 6, 2026, 6:37 PM EST

2.57 0.00 0.00%

After hours · Nov 6, 6:37 PM ET

2.48 Day range 2.63
1.66 52-week range 3.94
YTD
+25.37%
1 year
-4.46%

Discussion (212)

Sign in to join the discussion

Vivian O'Neal EDIT 6 years ago #102

Very good reads thank you. I think the risk/reward ratio is in our favor. Big pharmaceutical companies are already onboard. Brilliance trial results will be key going forward. If we can announce positive results there and get the IND in for sickle cell we will be in good shape

Vivian O'Neal EDIT 6 years ago #103

They will have update on the second patient dosing by year end as stated on cc CRSPR CHOOSES NOT TO HAVE CC BC THEY ARE SHOOTING IN THE DARK

Vivian O'Neal EDIT 6 years ago #106

We as investors must remember that stocks never go up in a straight line, there will be bumps along the way, some days weeks even months sellers will come in and dump shares on the market over the phone etc and eventually it subsides and they then get bid up and the cycle continues. Lot of stocks got ahead of themselves and some are just plain sells like zoom for example it will never grow into the valuation before competition comes in from a major player and takes them out. That is like buying pets.com instead of amazon back in the day. Stay long and strong and keep 10-30 percent in cash for the dips. God bless you all

Vivian O'Neal EDIT 6 years ago #107

This is a well needed V on the charts. It only creates more support going higher. One things for certain markets go up after they go down

Vivian O'Neal EDIT 6 years ago #108

How do you block these silly algorithms that are always opposite of what we should be doing